Literature DB >> 6709075

Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog.

M Q Paiva, M Caramona, W Osswald.   

Abstract

The uptake and metabolism of 3H-5-hydroxytryptamine (5-HT) in the isolated saphenous vein of the dog was studied, as well as the sensitivity to 5-HT and its termination of action (as determined by oil immersion experiments). After exposure of the vein to 0.23 mumol/1 5-HT for 30 min, about one half of the 5-HT removed was accumulated in the tissue, the other half appearing in the form of metabolites. Cocaine, chlorimipramine or denervation reduced the accumulation, but not the metabolism, of 5-HT; hydrocortisone reduced both accumulation and metabolism. Hydrocortisone plus cocaine (or phenoxybenzamine alone) caused a greater reduction of accumulation and metabolism than hydrocortisone or cocaine alone. Pargyline caused an increase in accumulation and virtually abolished metabolism; amezinium also abolished metabolism, but reduced accumulation (the same effects as caused by cocaine plus pargyline). Cocaine (12 mumol/l) caused supersensitivity to 5-HT and a prolongation of the half-time for relaxation in oil; hydrocortisone (40 mumol/l) had no effect on sensitivity, but prolonged somewhat the half-time for relaxation in oil, showing supra-additive effects with cocaine. 5-HT, taken up into adrenergic nerve terminals, was released by electrical stimulation; no appreciable reduction in fractional release occurred during repeated stimulations. Exposure to cocaine prior to incubation with 5-HT prevented the neuronal uptake of 5-HT. Compartmental analysis, done with the help of washout curves of strips pretreated with pargyline and loaded with 3H-5-HT, shows that 3H-5-HT distributed into 3 compartments plus a bound fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6709075     DOI: 10.1007/bf00507055

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Inactivation of norepinephrine in an isolated vein.

Authors:  F Brandao
Journal:  J Pharmacol Exp Ther       Date:  1977-10       Impact factor: 4.030

3.  The distribution of 3H-(+/-)noradrenaline in rabbit aortic strips after inhibition of the noradrenaline-metabolizing enzymes.

Authors:  M Henseling; E Eckert; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: its relationship to the metabolic fate of released norepinephrine.

Authors:  S Z Langer; M A Enero
Journal:  J Pharmacol Exp Ther       Date:  1974-12       Impact factor: 4.030

5.  Analysis of 5-HTP-C-14 and its metabolites.

Authors:  A Feldstein; K K Wong
Journal:  Anal Biochem       Date:  1965-06       Impact factor: 3.365

6.  A method for the study of mechanisms of drug disposition in smooth muscle.

Authors:  S Kalsner; M Nickerson
Journal:  Can J Physiol Pharmacol       Date:  1968-09       Impact factor: 2.273

7.  Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex.

Authors:  R F Squires
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

8.  On the mechanism of action of amezinium methylsulphate on the dog saphenous vein.

Authors:  D Araújo; M M Caramona; W Osswald
Journal:  Eur J Pharmacol       Date:  1983-06-03       Impact factor: 4.432

9.  Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

10.  The role played by the extraneuronal system in the disposition of noradrenaline and adrenaline in vessels.

Authors:  S Guimarães; M Q Paiva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-02       Impact factor: 3.000

View more
  10 in total

1.  Extraneuronal serotonin accumulation in peripheral arteries of the rat.

Authors:  S Fukuda; C Su; T J Lee
Journal:  Experientia       Date:  1986-12-01

2.  Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

3.  Dissipation mechanisms for 5-hydroxytryptamine in the coronary circulation of the isolated perfused heart of the rat.

Authors:  L J Bryan; S R O'Donnell; A M Williams
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

4.  A 5-hydroxytryptamine receptor in human atrium.

Authors:  A J Kaumann; L Sanders; A M Brown; K J Murray; M J Brown
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.

Authors:  L Cassis; J Ludwig; M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

6.  5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae.

Authors:  G S Baxter; D A Craig; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

7.  The substrate specificity of uptake2 in the rat heart.

Authors:  M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

8.  Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine.

Authors:  R A Cohen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.

Authors:  M Q Paiva; M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

10.  Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.